IP Library › Assignment 033416/0897
Patent Assignment
Reel/Frame 033416/0897

Security Interest

Recorded: 2014-07-25 Pages: 17
Assignor
TRIMEL BIOPHARMA SRL
Executed: 2014-07-16
Assignee
MIDCAP FUNDING V, LLC
7255 WOODMONT AVENUE, SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties (16)
Inhaler
Patent: 5,797,392 →
Application: 08/785,960 →
Method and Device for Introducing a Powdered or Particulate Substance into a Person's Nostril
Patent: 6,648,848 →
Application: 09/424,085 →
Method for Introducing a Powdered Substance into a Nostril
Patent: 6,811,543 →
Application: 10/142,688 →
Publication: US 2002/0165482
Inhaler
Patent: 7,661,425 →
Application: 10/595,445 →
Publication: US 2008/0190423
Intranasal Methods of Treating Women for Anorgasmia with 0.6% and 0.72% Testosterone Gels
Patent: 9,757,388 →
Application: 13/471,445 →
Publication: US 2013/0059827
Intranasal 0.45% and 0.48% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 13/471,449 →
Publication: US 2013/0040922
Intranasal 0.15% and 0.24% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 13/471,450 →
Publication: US 2013/0045958
Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application: 13/471,452 →
Publication: US 2013/0040923
Controlled Release Topical Testosterone Formulations and Methods
Application: 14/080,695 →
Methods of Treating Hypogonadism with Tranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application: 61/802,297 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 61/802,354 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application: 61/802,388 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 61/802,724 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application: 61/802,727 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application: 61/802,737 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application: 61/802,739 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 20, 2006
From: KELDMANN, TROELS; KELDMANN, ERIK; PALLOTTA, TERESA; MELO, FLAVIO
To: DIRECT HALER A/S
Reel/Frame 017502/0359 →
Assignment of Assignor's Interest Jul 11, 2012
From: KELDMANN HEALTHCARE A/S
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028531/0161 →
Change of Name Jul 11, 2012
From: DIRECT-HALER A/S
To: KELDMANN HEALTHCARE A/S
Reel/Frame 028546/0363 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028559/0484 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028559/0674 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028558/0907 →
Assignment of Assignor's Interest Jul 16, 2012
From: KREPPNER, WAYNE; FOGARTY, SIOBHAN; OBEREGGER, WERNER; MAES, PAUL
To: TRIMEL BIOPHARMA SRL
Reel/Frame 028558/0265 →
Security Agreement Jul 19, 2012
From: TRIMEL BIOPHARMA SRL
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028597/0285 →
Assignment of Assignor's Interest Jul 23, 2012
From: KELDMANN, ERIK; KELDMANN, TROELS; QUESADA, JORGE MARTINEZ; PELAEZ, RICARDO PALACIOS
To: DIRECT-HALER A/S
Reel/Frame 028615/0711 →
Security Agreement Jul 23, 2012
From: TRIMEL BIOPHARMA SRL
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028613/0855 →
Release of Security Interest Jul 25, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: TRIMEL BIOPHARMA SRL
Reel/Frame 033417/0094 →
Release of Security Interest Jul 25, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: TRIMEL BIOPHARMA SRL
Reel/Frame 033417/0304 →
Change of Name Sep 23, 2015
From: TRIMEL BIOPHARMA SRL
To: ACERUS PHARMACEUTICAL SRL
Reel/Frame 036667/0608 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 036667 Frame 0608. Assignor(S) Hereby Confirms the Assignment. Oct 7, 2015
From: TRIMEL BIOPHARMA SRL
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 036807/0886 →
Assignment of Assignor's Interest Oct 9, 2015
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 036827/0897 →
Change of Name Dec 20, 2017
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 044958/0562 →
Security Interest Jan 24, 2018
From: ACERUS BIOPHARMA INC.
To: QUANTIUS INC.
Reel/Frame 044719/0767 →
Release of Security Interest Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →
Intellectual Property Security Agreement Oct 11, 2018
From: ACERUS PHARMACEUTICALS CORPORATION; ACERUS BIOPHARMA INC.; ACERUS LABS INC.
To: SWK FUNDING LLC
Reel/Frame 047217/0760 →
Release of Security Interest Nov 2, 2018
From: QUANTIUS INC.
To: ACERUS PHARMACEUTICALS CORPORATION; ACERUS LABS INC.; ACERUS BIOPHARMA INC.
Reel/Frame 047399/0698 →
Assignment of Assignor's Interest Dec 19, 2019
From: TRIMEL BIOPHARMA SRL
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 051337/0832 →
Employment Agreement May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056284/0111 →
Employment Agreement May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056283/0289 →
Gudaitis Declaration Supporting Chain of Title May 13, 2021
From: TRIMEL BIOPHARMA INC.
To: ACERUS BIOPHARMA INC.
Reel/Frame 056252/0740 →
Change of Name May 13, 2021
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 056238/0484 →